PROSTATE cancer screening was reported less frequently among men with disabilities aged 55 to 69 years, according to a nationally representative analysis examining prostate specific antigen testing uptake in the USA.
The study assessed 10,508 survey respondents, representing an estimated 5,058,866 men nationwide, and explored whether disability status was associated with screening participation.
Researchers used 2023 data from a population-based health survey and evaluated self-reported prostate specific antigen testing among men aged 55 to 69 years.
Overall, 29.6% of participants reported at least one disability. Across the full cohort, 62.7% reported previous prostate specific antigen testing.
However, screening rates were lower among men with disabilities (57.2%) compared with those without disabilities (65.1%).
After adjustment for sociodemographic characteristics, insurance status, comorbidities, and health behaviours, disability remained associated with lower odds of prostate specific antigen testing.
A sensitivity analysis produced similar findings, supporting the robustness of the observed association.
The analysis also examined individual disability categories. Men with cognitive, vision, self-care, and independent living disabilities generally reported lower screening uptake than those without disabilities.
Hearing disability showed screening rates comparable to men without disabilities.
Among the disability subtypes assessed, mobility disability demonstrated the most consistent association with reduced screening.
In adjusted analyses, men with mobility disability had significantly lower odds of undergoing prostate specific antigen testing.
The researchers concluded that disability may represent an under recognised determinant of preventive healthcare access.
The findings highlighted a persistent inequity in prostate cancer screening and suggested that men with mobility limitations may face particular barriers to participating in screening discussions and services.
According to the authors, further research is needed to better understand the factors driving these disparities and to inform interventions that support equitable access to shared decision making and screening opportunities.
Reference
Nolazco JI et al. Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years. JAMA Netw Open. 2026;9(8):e2627708
Featured image: Theron/peopleimages.com on Adobe Stock
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
